Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Orexia Therapeutics discovers orexin OX2 receptor agonists

March 31, 2022

Researchers present new Slc39a14-knockout dystonia murine model

March 30, 2022

Protein is marker, target for diabetic neuropathy

March 30, 2022

Alpha Cognition reports in vivo and in vitro data on ALPHA-0602 for ALS

March 30, 2022

Novel ferroptosis inhibitor mitigates cerebral ischemic injury in rat

March 30, 2022

Cybin completes in vivo studies for deuterated psilocybin analogue CYB-003 for MDD

March 30, 2022

New G2019S mutant leucine-rich repeat kinase 2 inhibitors discovered at Merck & Co.

March 30, 2022

Friedrich-Alexander-University Erlangen-Nuremberg presents mu-opioid receptor agonists

March 29, 2022

Novel USP30 inhibitors as potential anti-Parkinson candidates

March 28, 2022

Bayer patents P2X purinoceptor 4 antagonists

March 28, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 18, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
NTX-819, a novel mGlu7 NAM for psychiatric disorders
BioWorld Science
Increasing evidence supports metabotropic glutamate mGlu7 receptor as a promising target in psychiatric disorders. Neurosterix Pharma Sarl has presented data on...
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...